Good news | Hardcore breakthrough! Jinyuankang's three liquid culture media have been registered as first-class medical device products, and the company has successfully obtained the qualification for production registration!

Introduction: Qualification landing, intelligent manufacturing sets sail! Inner Mongolia Jinyuankang Bioengineering Co., Ltd. welcomes another milestone in its development. All three self-developed liquid culture medium products have obtained the first category medical device pro···

Chain Innovation! Shenzhen Advanced Institute and China Europe Medical Center visit Jinyuankang Biotechnology to jointly build a new ecology of CGT and cell medicine industry

CREATE LINKRecently, Wu Chuangzhi, Secretary of the Party Committee of the Shenzhen Advanced Technology Research Institute of the Chinese Academy of Sciences (hereinafter referred to as "Shenzhen Advanced Institute"), Qiu Liyang, Head of the Innovation R&D Center of···

From cells to solutions: Jinyuankang's one-stop R&D empowerment panorama

Cells are silent, yet they carry the weight of life sciences; The process is intangible, but it determines the success or failure of product conversion.On the long road of biopharmaceuticals, the real "roadblocks" are often not grand theories, but deviations in petri di···

When Industry Leaders Meet National Strategic Technological Forces - "Deep Blue Dialogue" between Jinyuankang Biotechnology and Shenzhen University of Technology

Stable quality and accurate results. These six words are written on the front page of every product manual of Jinyuankang Biotechnology, and also engraved in the 26 year development gene of this enterprise.The spring breeze of April brushes over the hot soil where Jinyuankang Bio···

Countdown to the implementation of Order No. 818: The cell therapy industry welcomes its "first year of compliance", with the logic of upstream raw materials being completely rewritten

There is less than a month left until May 1st, 2026.On this day, the "Regulations on the Administration of Clinical Research and Clinical Translational Application of Biomedical New Technologies" (State Council Decree No. 818) will officially come into effect. This is t···

The ISIA Journey of a Chinese Enterprise: Jinyuankang's "Reliable" Response

On the official membership list of the International Serum Industry Association (ISIA), there is a company from Inner Mongolia, China - Jinyuankang Biotechnology.ISIA is the most authoritative international organization recognized in the serum industry. Its membership directory i···

Notice of Changes in AoPusai Scientific Research to Jinyuankang Scientific Research Label, etc

Dear customer:Hello!Thank you for your trust and support in Inner Mongolia AoPusai Biotechnology Co., Ltd. Over the years, in response to the group's strategic development plan and in coordination with the business direction adjustment of its wholly-owned subsidiary Inner Mon···

The grand event of Ludao has come to a successful conclusion | Jinyuankang Biotechnology shines at 2026 CACLP, drawing a new picture of IVD with its "diagnostic chip" strength

2026.3.21-3.23Xiamen, ChinaIn March on Egret Island, the sea breeze blows gently and the spring scenery is just right.From March 21st to 23rd, the 23rd China International Laboratory Medicine and Blood Transfusion Instrument Reagent Expo (CACLP) and the 6th China International IV···

Jinyuankang Biotech P2 Laboratory: A Strategic Move for the Future of the Industry

In recent years, with the rapid development of gene therapy, cell therapy, and new vaccines, serum, as the core raw material in the upstream of biopharmaceuticals, has seen its quality and compliance raised to an unprecedented level. The Biosafety Level 2 (BSL-2, abbreviated as P···

Historic tone setting! Biomedicine has become an "emerging pillar industry"! Jinyuankang Biotech takes the lead in unveiling the "new chessboard"

On March 11, 2026, Beijing witnessed the conclusion of the National People's Congress and the Chinese People's Political Consultative Conference. A historic change swept through the social media circles of the biomedical industry: for the first time, biomedicine was expli···